Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia. 1998

S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
Department of Pediatrics, University of Washington, Seattle 98195, USA. snonoyama.ped@med.tmd.ac.jp

X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused by mutations of Bruton tyrosine kinase (Btk); Btk plays an essential role in the development of mature B cells. However, small numbers of B cells ("leaky B cells") are present in the peripheral blood of most XLA patients. In this study, we analyzed the function of these leaky B cells obtained from XLA patients. Enough numbers of B cells were available for analysis from five of nine XLA patients originally screened. Sequence analysis revealed missense mutations of Btk in four of the five XLA patients. No mutation was found in the coding region of Btk in one patient. Western blotting and/or flow cytometric analysis failed to detect Btk protein in all five patients. B cells isolated from peripheral blood of these XLA patients were CD5-, CD20+, CD19+, and CD21-. If stimulated with anti-CD40 and IL-4, XLA B cells proliferated normally and produced significant amounts of IgE. Anti-CD40 stimulation of XLA B cells resulted in normal expression of CD23. In addition, three of the five XLA patients studied were immunized with bacteriophage phiX174 and produced low but detectable levels of antiphage-specific Ab. Similarly, X-linked immunodeficiency mice, which carry a missense mutation in Btk, produced substantial amounts of antiphage Ab. These results indicate that CD40 signaling is intact in B cells lacking demonstrable Btk, and that leaky B cells in XLA patients can proliferate, undergo isotype switching, and differentiate into specific Ab-producing cells.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077329 Agammaglobulinaemia Tyrosine Kinase A non-receptor tyrosine kinase that is essential for the development, maturation, and signaling of B-LYMPHOCYTES. It contains an N-terminal zinc finger motif and localizes primarily to the PLASMA MEMBRANE and nucleus of B-lymphocytes. Mutations in the gene that encode this kinase are associated with X-LINKED AGAMMAGLOBULINEMIA. B Cell Progenitor Kinase,Bruton's Tyrosine Kinase,Bruton Tyrosine Kinase,Brutons Tyrosine Kinase,Kinase, Agammaglobulinaemia Tyrosine,Kinase, Bruton's Tyrosine,Tyrosine Kinase, Agammaglobulinaemia,Tyrosine Kinase, Bruton's
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000361 Agammaglobulinemia An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood. Hypogammaglobulinemia,Agammaglobulinemias,Hypogammaglobulinemias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
May 1985, Journal of immunology (Baltimore, Md. : 1950),
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
January 1983, Birth defects original article series,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
November 1993, Journal of immunological methods,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
May 1985, Medicine,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
June 1989, The Journal of experimental medicine,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
August 2003, Transplantation proceedings,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
January 2000, Ryoikibetsu shokogun shirizu,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
October 2000, Clinical reviews in allergy & immunology,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
April 2016, Indian journal of pediatrics,
S Nonoyama, and S Tsukada, and T Yamadori, and T Miyawaki, and Y Z Jin, and C Watanabe, and T Morio, and J Yata, and H D Ochs
November 1991, Clinical immunology and immunopathology,
Copied contents to your clipboard!